Abcellera Biologics Inc (ABCL)

Mar 12, 2025

What To Expect From AbCellera Biologics Inc (ABCL) Q4 2024 Earni - GuruFocus.com

Mar 12, 2025

Mar 11, 2025

Thermopylae holdings acquires $742,242 in AbCellera shares - Investing.com India

Mar 11, 2025

Mar 11, 2025

Major Stakeholder Makes Bold Move with AbCellera Biologics Stock Purchase! - TipRanks

Mar 11, 2025

Mar 10, 2025

AbCellera biologics director John Montalbano acquires $57,499 in shares By Investing.com - Investing.com South Africa

Mar 10, 2025

Mar 10, 2025

AbCellera biologics director John Montalbano acquires $57,499 in shares - Investing.com India

Mar 10, 2025

Mar 10, 2025

Abcellera stock hits 52-week low at $2.20 amid market challenges - Investing.com

Mar 10, 2025

Mar 09, 2025

Independent Non-Employee Director of AbCellera Biologics Picks Up 66% More Stock - Simply Wall St

Mar 09, 2025

Mar 07, 2025

Director Makes Bold Move with Major Stock Purchase in AbCellera Biologics - TipRanks

Mar 07, 2025

Mar 07, 2025

Abcellera Biologics director Montalbano buys $140,568 in shares By Investing.com - Investing.com South Africa

Mar 07, 2025

Mar 07, 2025

Abcellera Biologics director Montalbano buys $140,568 in shares - Investing.com

Mar 07, 2025

Mar 06, 2025

Q1 Earnings Estimate for ABCL Issued By Bloom Burton - Defense World

Mar 06, 2025

Mar 05, 2025

Sanctuary Advisors LLC Decreases Stake in AbCellera Biologics Inc. (NASDAQ:ABCL) - Defense World

Mar 05, 2025

Mar 04, 2025

AbCellera Biologics’ (ABCL) Hold Rating Reaffirmed at Benchmark - Defense World

Mar 04, 2025

Mar 03, 2025

Benchmark maintains Hold on AbCellera stock, no price target change - Investing.com

Mar 03, 2025

Mar 03, 2025

Benchmark maintains Hold on AbCellera stock, no price target change By Investing.com - Investing.com UK

Mar 03, 2025

Mar 01, 2025

Stifel Nicolaus Issues Pessimistic Forecast for AbCellera Biologics (NASDAQ:ABCL) Stock Price - MarketBeat

Mar 01, 2025

Mar 01, 2025

AbCellera Biologics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance UK

Mar 01, 2025

Mar 01, 2025

AbCellera Biologics (NASDAQ:ABCL) Reaches New 52-Week Low on Analyst Downgrade - MarketBeat

Mar 01, 2025

Feb 28, 2025

AbCellera Biologics (ABCL) Projected to Post Earnings on Thursday - MarketBeat

Feb 28, 2025

Feb 28, 2025

AbCellera Biologics (NASDAQ:ABCL) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

AbCellera Biologics (NASDAQ:ABCL) Posts Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

AbCellera Biologics’ Earnings Call: Transition Amid Challenges - TipRanks

Feb 28, 2025

Feb 28, 2025

Abcellera stock hits 52-week low at $2.33 amid market challenges - Investing.com India

Feb 28, 2025

Feb 28, 2025

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates - MSN

Feb 28, 2025

Feb 28, 2025

AbCellera Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com

Feb 28, 2025

Feb 28, 2025

AbCellera Biologics Inc. (NASDAQ:ABCL) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 28, 2025

Feb 28, 2025

AbCellera Biologics Inc (ABCL) Q4 2024 Earnings Call Highlights: Strategic Shifts Amid ... - Yahoo Finance

Feb 28, 2025

Feb 27, 2025

AbCellera Biologics Reports 2024 Financial Results - TipRanks

Feb 27, 2025

Feb 27, 2025

Abcellera Biologics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025

Feb 27, 2025

AbCellera Reports Full Year 2024 Business Results - sharewise

Feb 27, 2025

Feb 27, 2025

Abcellera Biologics earnings beat by $0.01, revenue fell short of estimates - Investing.com

Feb 27, 2025

Feb 27, 2025

AbCellera Biologics (ABCL) Q4 2024 Earnings Call Transcript - MSN

Feb 27, 2025

Feb 27, 2025

AbCellera Biologics Reports 2024 Financial Results and Growth - TipRanks

Feb 27, 2025

Feb 27, 2025

AbCellera Biologics Inc. SEC 10-K Report - TradingView

Feb 27, 2025

Feb 27, 2025

AbCellera Biologics Q4 2024 Earnings Preview - MSN

Feb 27, 2025

Feb 27, 2025

Earnings Scheduled For February 27, 2025 - Benzinga

Feb 27, 2025

Feb 26, 2025

What To Expect From AbCellera Biologics Inc (ABCL) Q4 2024 Earnings - Yahoo Finance

Feb 26, 2025

Feb 24, 2025

AbCellera Biologics (NASDAQ:ABCL) Trading Down 8.5%Here's What Happened - MarketBeat

Feb 24, 2025

Feb 22, 2025

AbCellera Biologics (NASDAQ:ABCL) Shares Gap UpShould You Buy? - MarketBeat

Feb 22, 2025

Feb 19, 2025

This Healthcare Stock Rose Sharply On USPTO Issuance - The Globe and Mail

Feb 19, 2025

Feb 18, 2025

AbCellera reassigns COO to CTO role, dissolves position - Investing.com India

Feb 18, 2025

Feb 18, 2025

AbCellera Biologics Changes COO's Title to Technology Chief -February 18, 2025 at 12:57 pm EST - Marketscreener.com

Feb 18, 2025

Feb 18, 2025

AbCellera reassigns COO to CTO role, dissolves position By Investing.com - Investing.com South Africa

Feb 18, 2025

Feb 18, 2025

One AbCellera Biologics Insider Raised Their Stake In The Previous Year - Yahoo Finance

Feb 18, 2025

Feb 17, 2025

Abcellera Biologics, other AI health stocks gain as Ellison touts AI's promise - MSN

Feb 17, 2025

Feb 16, 2025

AbCellera Biologics Inc. (NASDAQ:ABCL) Short Interest Update - MarketBeat

Feb 16, 2025

Feb 16, 2025

AbCellera Biologics (ABCL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat

Feb 16, 2025

Feb 14, 2025

AbCellera Biologics (ABCL) to Release Earnings on Tuesday - MarketBeat

Feb 14, 2025

Feb 14, 2025

Moloney Securities Asset Management LLC Takes $265,000 Position in AbCellera Biologics Inc. (NASDAQ:ABCL) - MarketBeat

Feb 14, 2025

Feb 12, 2025

AbCellera to Participate at Upcoming Investor Conferences in March 2025 - BioSpace

Feb 12, 2025

Feb 11, 2025

AbCellera Biologics (NASDAQ:ABCL) Shares Down 5%Time to Sell? - MarketBeat

Feb 11, 2025

Feb 11, 2025

AbCellera to Participate at Upcoming Investor Conferences in March - The Globe and Mail

Feb 11, 2025